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MEDICAL RESEARCH DATA-SHARING: 
THE ‘PUBLIC GOOD’ AND VULNERABLE GROUPS 
 
Dr. Shawn H.E. Harmon∗ 
Kuan-Hsun Chen∗ 
 
Abstract: One of the moral tests of governments is how they treat 
those in the twilight of life (the elderly).  As such, it is important not 
only to take care of the needs of the elderly, but also to place their 
reality in the forefront of deliberations and actions.  Now that we are in 
the so-called ‘century of biology’, we must ensure that the newly 
transformed and increasingly relied on biosciences not only respond to 
the needs of the elderly but also reflect the reality of the elderly.  While 
many arguments can be made in support of increased data-sharing in 
biomedical research (and indeed within and across healthcare systems 
more generally), there are some persuasive age-based arguments that 
might serve to encourage science regulators, through both funding 
structures and the law, to fundamentally reshape the research 
environment so as to enhance its potential to achieve public goods 
such as improved health and more effective healthcare systems.  In this 
paper, after noting the new research model arising from population 
genomics, with its intense data needs, we advance three age-based 
arguments, in favour of increased and improved data-sharing, and we 
conclude with some brief observations about how increased data-
sharing might be achieved. 
 
Keywords: aging; healthcare; biomedical research; data-sharing; 
human rights; values; solidarity; reciprocity; altruism 
 
INTRODUCTION 
 
In claiming that the moral test of governments is how they treat those who are in the 
dawn of life (children), the twilight of life (the elderly), and the shadows of life (the 
sick, needy, and handicapped),1 Hubert Humphrey highlighted the importance not 
only of taking care of the needs of those in the margins, but of placing their reality in 
the forefront of deliberations and actions, even where they may seem not to be 
directly relevant.  In claiming that the 21st century would be the ‘century of biology’,2 
Nobel Laureate Robert Curl anticipated the growth and transformation of the 
biosciences, and appreciated the increasing reliance that would be placed on them 
                                                 
∗  Lecturer in Regulation & Risk, School of Law, University of Edinburgh; Co-Director, J 
Kenyon Mason Institute for Medicine, Life Sciences and the Law; Research Fellow, Innogen, ESRC 
Centre for Social and Economic Research on Innovation in Genomics, University of Edinburgh; 
Research Fellow in Medical Law & Technologies, SCRIPT, AHRC Centre for Research on Intellectual 
Property and Technology Law, University of Edinburgh; Joint Editor-in-Chief, Medical Law 
International. 
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1  H. Humphrey, Remarks at the Dedication of the Hubert H. Humphrey Building on 1 
November 1977, Congressional Record, 4 November 1977, vol. 123, p. 37287. 
2  J. Rifkin, “The Biotech Century: Playing Ecological Roulette with Mother Nature’s Design”, 
E: The Environmental Magazine, May-June 1998, available at 
http://findarticles.com/p/articles/mi_m1594/is_n3_v9/ai_20581506/?tag=content;col1. 
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despite the risks that their outputs represent.  These two concerns – needs of, and 
pressures created by, the vulnerable on the one hand, and the needs of, and 
possibilities for, the biosciences on the other – inform the central argument of this 
paper, which is that science regulators, through both funding structures and the law, 
should fundamentally reshape the research environment so as to increase and improve 
data-sharing amongst researchers and primary research users. 
Calls abound to assess existing rules and practices with a view to fashioning a 
new consensus that enables research while respecting the rights and obligations of all 
stakeholders,3 and this paper contributes to that endeavour, taking into account ‘public 
goods’ and ‘vulnerable populations’.  While a compelling science-based argument can 
be made for increased data-sharing (ie: for more ‘open science’), we draw on science 
only to demonstrate that research models are changing (or rather diversifying), and 
that new and emerging models, particularly those in the population genomics setting, 
demand increased and improved data-sharing if they are to achieve their promise.  
This insight serves as a preliminary argument to the primary argument, which is that 
better acknowledgement of the rights of, pressures created by, and duties toward 
vulnerable groups serves the overall public good, and offers an additional justification 
for improved data-sharing.   
While any number of vulnerable groups might serve as a legitimate case study, 
particularly where that vulnerability stems from being at or near the end of life (eg: 
high risk or terminal cancer patients might illustrate the argument), we focus on the 
elderly.  And while the elderly are not a homogenous group, for present purposes we 
assume the elderly, as an aggregated group, to be: 
 
• seventy years-old or over; 
• entering a life-stage of increasing infirmity which, in addition to potential 
sudden and profound health degradations, is likely to involve chronic health 
conditions; and 
• more frequent and more cost-intensive users of healthcare services. 
 
After briefly articulating the preliminary science-based argument for increased data-
sharing, we move to our main (non-science-based) argument.  We advance a rights 
claim, a systems claim, and an ethical claim in support of the position that the elderly 
(as one of a number of vulnerable groups), through their rights-holding, healthcare 
system usage, and research participation, justify increased data-sharing.4  We 
conclude with some brief observations about how increased data-sharing might be 
achieved, but we must stipulate that we do not intend to offer a fully-designed legal 
regime; such is beyond the scope of the paper. 
 
PRELIMINARY ARGUMENT: DATA NEEDS IN NEW SCIENCE MODELS 
 
Now well into the 21st century, we can see, as Curl predicted, that the biosciences are 
rising in scientific and social significance.  Indeed, the biosciences themselves are 
transforming with respect to how they are conceptualised and studied.  Frequently 
                                                 
3  Representations at the International Data Sharing Conference, hosted by HeLEX, in Oxford, 
on 20-22 September 2010, and those directed at the Oxford Call to Action, which is emerging 
therefrom.  See http://www.publichealth.ox.ac.uk/helex/events/data-sharing-international-conference-1. 
4  We emphasise that this is not a defence of the taking or using or medical data from tissue or 
from healthcare records, but rather a demand for the improved use of data already obtained presumably 
through legitimate processes. 
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shaped by computational and engineering metaphors, they are increasingly cellular, 
longitudinal, fragmented, and data-reliant.  The new research model bears the 
following features:5 
 
• It is increasingly based on genomic investigations, and on whole-genome 
research and thus has a built-in reliance on metadata and massive sample 
sizes.6  Thus, it is dependent on newly developed and quickly evolving 
technologies in the bioinformatics and related fields, particularly high-
throughput sequencing technologies with high computational capacities.7 
 
• It is increasingly interdisciplinary and segmented.  Its scale and complexity 
(ie: testing gene-to-gene and genetic-environmental factors in the 
development, progress, and possible treatment of diseases) means that 
research is often collaborative and reliant on collections of individuals with 
different skills and backgrounds and highly differentiated and sometimes 
narrow tasks (eg: principal investigator, recruitment or sample collection team, 
sequencing team, data analysis team, including informaticians and 
statisticians, data repository curators, etc.).8  This diffusion of responsibilities 
across institutions, both academic and commercial, and across national 
borders, means that data must be shared within projects and beyond the 
collecting team.  Some tissue (and associated data) is collected and retained 
specifically for distribution to secondary researchers of diverse background 
and interest, a practice which is widely considered to be of significant 
scientific, healthcare and commercial value.9 
 
• It often has little expectation of immediate outcomes capable of translation 
into clinical practices.  Population-based genomic research in the form of 
biobanks, both ‘primary’ and ‘secondary’,10 is an example of this, and they are 
                                                 
5  For more on the new model, see House of Lords Science & Technology Committee, 2nd 
Report of Session 2008–09: Genomic Medicine (London: Stationary Office, 2009), available at 
http://www.publications.parliament.uk/pa/ld200809/ldselect/ldsctech/107/107i.pdf. 
6  Digital Archiving Consultancy et al., Large-Scale Data Sharing in the Life Sciences: Data 
Standards, Incentives, Barriers and Funding Models (2005), available at 
http://dtl.unimelb.edu.au/R/USXD3V19SHBSCYV36CNMIT6TYTHGK7UQDYYD1PLMCMULA18
9CE-00409?func=dbin-jump-full&object_id=263978&pds_handle=GUEST. 
7  C. Shaffer, “Next-Generation Sequencing Outpaces Expectations” (2007) 25 Nature Biotech 
149. 
8  M. Gibbons et al., The New Production of Knowledge: The Dynamics of Science and Research 
in Contemporary Societies (London: Sage, 1994), J. Ziman, Real Science: What It Is and What It 
Means (Cambridge: CUP, 2000), others. 
9  J. Kaiser, “Population Databases Boom: From Iceland to the US” (2002) 298 Science 1158-
1161. 
10  Primary biobanks generate new data collections for defined purposes.  An example includes 
the UK Biobank, a repository of biological samples and health data from some 500,000 volunteers 
between the ages of 40-69 aimed at helping scientists develop better methods of prevention, diagnosis, 
and treatment for combating the conditions of old age, and to thereby improve the health of future 
generations: see http://www.ukbiobank.ac.uk/.  Secondary biobanks aggregate and manage samples and 
data originated by others for specific purposes but which now may be valuable for other research 
purposes.  An example is the UK DNA Banking Network which aims to provide data to genome-wide 
association studies which seek to identify multiple loci which contribute to genetic risk for given 
diseases: see http://www.dna-network.ac.uk/, and see M. Yuille et al., “The UK DNA Banking 
Network: A ‘Fair Access’ Biobank” (2010) 11 Cell Tissue Bank 241-251. 
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experiencing a boom.11  Such biobanks are: (1) collective (reliant on mass 
participation); (2) inclusive (include healthy people and even children); (3) 
prospective (enduring for a long time into the future and ideally beyond the 
life of original participants); and (4) purposively indeterminate (not tied to a 
single objective).12 
 
Ultimately, modern research exhibits a complexity of scientific questions, of methods 
for answering them, and of answers being offered, and a complexity of research 
organisation (which sometimes has a complete separation of resource and/or data 
collection and data deployment, or analysis and interpretation).13 
In light of this universally-experienced complexity, one might have expected a 
common method of data-sharing to emerge.  However, there is no common method or 
common approach.  Most data-sharing occurs on an ad hoc or project-grounded basis, 
and much of it is reliant on personal relationships.14  Additionally, there is no common 
(cross-jurisdictional) instruction on data-sharing.  It is governed, to the extent that it is 
governed at all, by professional standards or practices, research funder demands, and 
non-binding international declarations, and for those who do not require public funds 
(or public partnerships), there are no binding guidelines whatsoever.  In short, despite 
the greater and growing demand for readily available data, and the widespread 
recognition that data-sharing, as a matter of course, accelerates the progress of 
research and its translation into socially useful products or practices,15 efficient, 
effective, and systematised data-sharing has not (yet) become the norm. 
Campbell et al. conducted a survey of geneticists in the USA which indicated 
that, in the previous three years, 47% of respondents had denied at least one request 
for data, information or material on published results.16  Bovenberg conducted a web-
survey of 118 human geneticists in 15 countries in which 51% of respondents 
indicated that they did not grant access to their databases to non-commercial 
entities.17  The Royal Netherlands Academy of Sciences conducted a web-survey on 
Dutch population cohorts and patient databases which indicated that 1.5% of 
respondents made their anonymised data publicly available, 73.3% permitted access 
on special terms and conditions, and 15% did not give access.18  Blumenthal et al. 
                                                 
11  B. Elger & A. Caplan, “Consent and Anonymization in Research Involving Biobanks” (2006) 
7 EMBO Reports 661-666. 
12  For more on them, see G. Williams, “Bioethics and Large-Scale Biobanking: Individualistic 
Ethics and Collective Projects” (2005) 1 Genomics Society Policy 50-66, and S. Harmon, “Semantic, 
Pedantic or Paradigm Shift? Recruitment, Retention and Property in Modern Population Biobanking” 
(2008) 16 European J Health Law 27-43. 
13  The problems that this reality poses for consent have been discussed in S. Harmon, ibid.  For 
an attempt to address some of these issues, see M. Angrst, “Eyes Wide Open: The Personal Genome 
Project, Citizen Science and Veracity in Informed Consent” (2009) 6 Personalised Medicine 691-699. 
14  J Kaye et al., “Data Sharing in Genomics: Reshaping Scientific Practice” (2009) 10 Nature 
Rev Gen 331-335. 
15  J. Walker et al., “The Value Of Health Care Information Exchange And Interoperability” 
(2005), available at http://www.partners.org/cird/pdfs/CITL_HIEI_Report.pdf, P. Arzberger et al., 
“Promoting Access to Public Research Data for Scientific, Economic and Social Development” (2004) 
3 Data Sci J 135-152,  H. Piwowar et al., “Sharing Detailed Research Data Is Associated with Increased 
Citation Rate” (2007) 2 PLoS ONE e308, P. Schofield et al., “Post-Publication Sharing of Data and 
Tools” (2009) 461 Nature 171-173. 
16  E. Campbell et al., “Data Withholding in Academic Genetics: Evidence from a National 
Survey” (2002) 287 JAMA 473-480. 
17  J. Bovenberg, “Blood, Sweat and Grants: ‘Honest Jim’ and the European Database-Right” 
(2005) 1 Genomics Society Policy 1-28. 
18  Ibid. 
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conducted a survey of university-based life science researchers in the US which found 
that data withholding is common, takes multiple forms, is influenced by a range of 
investigator characteristics, and varies by field.19 
More recent evidence suggests that this situation has not dramatically 
improved.20  A Joint Statement issued by an international collection of funders further 
confirms it: 
 
In some research fields … data sharing is well-established and has 
accelerated the progress of research and its application for the public 
good.  In public health research, however … the sharing of data is not 
yet the norm, even within the scientific community.21 
 
All told, the prevailing research environment hinders effective data- and knowledge-
sharing and therefore the more timely delivery of useful products and practices,22 and 
so cannot be considered fit-for-purpose.  One aspect of that sub-optimal environment 
is the regulatory milieu; research positively wallows in instruction, which exhibits a 
volume and complexity that naturally dissuades sharing.  With respect to genomic 
medicine, Andrew Morris, Chairman of the Generation Scotland Scientific 
Committee, reported the following in 2008: 
 
The Department of Health guidance suggests that this domain [the use of 
health records for genomic research] is affected by 43 relevant pieces of 
legislation.  There were 12 sets of relevant standards and 8 professional 
codes of conduct.  What this has bred is a culture of caution, confusion, 
uncertainty and inconsistency.23 
 
It has also been claimed that: 
 
… [T]here is evidence that UK health research activities are being 
seriously undermined by an overly complex regulatory and governance 
environment. … New regulatory bodies and checks have been 
introduced with good intentions, but the sum effect is a fragmented 
process characterised by multiple layers of bureaucracy, uncertainty in 
the interpretation of individual legislation and guidance, a lack of trust 
within the system, and duplication and overlap in responsibilities.24 
                                                 
19  D. Blumenthal et al., “Data Withholding in Genetics and the Other Life Sciences: Prevalences 
and Predictors” (2006) 81 Academic Medicine 137-145. 
20  See Wellcome Trust Press Release, “Global Funding Agencies Commit to Enhancing Access 
to Research Data to Improve Public Health”, 10 January 2011, available at 
http://www.wellcome.ac.uk/News/Media-office/Press-releases/2011/WTX064132.htm. 
21  Research Funders, Sharing Research Data to Improve Public Health: Joint Statement of 
Purpose, January 2011, available at http://www.wellcome.ac.uk/About-us/Policy/Spotlight-issues/Data-
sharing/Public-health-and-epidemiology/WTDV030690.htm. 
22  So claimed by M. Yuille in comments posted at http://helexoxford.com/content/oxford-
statement-data-sharing in relation to the International Data Sharing Conference, hosted by HeLEX, in 
Oxford, on 20-22 September 2010, and so noted in Academy of Medical Sciences, A New Pathway for 
the Regulation and Governance of Health Research (London: AMS, 2011). 
23  House of Lords Science and Technology Committee, supra, note 5, at para. 6.15. 
24  AMS, supra, note 22, at 2 and 3.  A position confirmed by the HFEA, HTA and MHRA when 
they conceded the need for their Interim UK Regulatory Route Map for Stem Cell Research & 
Manufacture, available at 
http://www.keele.ac.uk/research/istm/HTA/Governance/Interim%20UKSC%20routemap.pdf. 
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The overlapping regulatory systems which prevail erect sometimes vague and often 
conflicting demands and standards.  This, together with the many actors and interests 
at play, makes confidently operating (and data-sharing) within the research 
environment very difficult.  Despite these hurdles, a number of recent research 
projects have adopted open data-sharing practices as a means of generating impact 
(eg: HapMap Project,25 1000 Genome Project,26 Database of Genotypes and 
Phenotypes,27 Genetic Association Information Network,28 Wellcome Trust Case 
Control Consortium,29 and Nottingham Arabidopsis Stock Centre30), but these 
examples are singular and pragmatic.  In any event, all of this supports the argument 
that the new research model demands new and more harmonised/standardised 
approaches to increased and more rapid data-sharing, but, as noted above, arguments 
in support of data-sharing are not limited to the scientific. 
 
PRIMARY ARGUMENT: CONSIDERATION OF THE VULERNABLE 
CREATES AN IMPERATIVE FOR DATA-SHARING 
 
Our primary argument, very simply, is that the unfolding demographic shift that 
society is experiencing favours increased and improved data-sharing in bioscience 
research.  A serious recognition of the realities of an aging population could and 
should lead to changes in scientific practices, including changes to data-sharing.  We 
have been called upon to pay much more attention to the needs, contributions, and 
rights of elderly people,31 and we must therefore reconsider their role as (1) health 
rights holders (ie: what is owed to the elderly), (2) as healthcare recipients (ie: the 
                                                 
25  The HapMap Project (2002-2007) was a multi-country collaboration among scientists and 
agencies from Canada, China, Japan, Nigeria, the United Kingdom and the United States aimed at 
identifying and cataloguing human genetic similarities and differences and thereby discovering genes 
that affect health, disease, and individual responses to medicines and environmental factors.  See  
http://hapmap.ncbi.nlm.nih.gov/thehapmap.html.en. 
26  The 1000 Genome Project (2007-) is a human genome reference project aimed at finding the 
most genetic variants that have frequencies of at least 1% in the populations studied.  See 
http://www.1000genomes.org/about. 
27  The dbGaP is a repository for archiving and distributing the study documents, phenotypic 
data, genetic data, and statistical results of studies that have investigated the interaction of genotype 
and phenotype.  Such studies include genome-wide association (GWA) studies, medical sequencing, 
molecular diagnostic assays, as well as association between genotype and non-clinical traits.  See 
http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/about.html. 
28  GAIN is a public-private partnership which invites data from investigators of existing case-
control or trio (parent-offspring) studies, and it supports GWA studies designed to identify the relation 
between specific DNA variation and particular common diseases.  Data is held in a database at the 
National Library of Medicine at the NIH for further use by other researchers.  GAIN gives data 
producers a six month publishing lead over competitors.  Requests for access are considered by an NIH 
Data Access Committee.  See http://www.genome.gov/19518664. 
29  The WTCCC is a collaboration of UK-based geneticists analysing thousands of DNA samples 
from a range of specific GWA studies aimed at identifying common genetic variations for different 
diseases.  While some data is available on the internet, genotypic and phenotypic data is obtained by 
application to the Consortium Data Access Committee.  See http://www.wtccc.org.uk/. 
30  NASC offers a transcriptomics service to process samples and RNA with Affymetrix gene 
chips.  It makes all donated data publicly available after a confidentiality period of 3, 6, or 12 months, 
depending in what donors/customers choose; the length of the confidentiality period is linked to the 
priority that donors demand for analysis service (ie: a request for quick processing results in the 
provision of a shorter confidentiality period).  See http://affymetrix.arabidopsis.info/. 
31  An avalanche of policy documents on this exists, but see T. Nilstrum & R. Ohlsson, “Should 
Health Care be Rationed by Age?” (1995) 23 Scan J Social Med 81-84. 
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health pressures the elderly generate), and (3) as research participants (ie: how the 
elderly are engaged with medical research).  While each of these perspectives have a 
moral element or character, we classify them as a rights argument (Argument 1), a 
systemic argument (Argument 2), and an ethical argument (Argument 3).   
 
Argument 1: Elder Rights and Health Rights Demand Healthcare Solutions 
 
The first age-based argument is a rights-based argument (and a cognizance of these 
rights should be retained throughout).  Broadly, it is as follows: We have worked very 
hard over the last 60+ years to create a ‘rights society’;32 indeed the rights paradigm is 
becoming the dominant socio-legal paradigm around the world.  Certain human 
rights, some of them directly relating to health and/or to the elderly, demand that we 
do more to support the health of the elderly.  One way to better operationalise these 
rights is to better support data-sharing. 
Everyone, including the elderly, has a right to the highest attainable standard 
of physical and mental health, and the right to a standard of living adequate for their 
health and needs, including, inter alia, medical care and social services.  This so-
called ‘right to health’ is contained in a plethora of international instruments, some of 
them legally binding, including the Universal Declaration of Human Rights (1948) 
(UDHR),33 the WHO Constitution (1948),34 the International Covenant on Economic, 
Social and Cultural Rights (1966) (ICESCR),35 the International Convention on the 
Elimination of All Forms of Racial Discrimination (1966),36 the Declaration of Alma-
Ata (1978),37 the Ottawa Charter for Health Promotion (1986),38 the Convention on 
the Rights of the Child (1990),39 and the Bangkok Charter for Health Promotion in a 
Globalised World (2005).40 
While sometimes viewed as an aspirational rather than an enforceable right, 
the ‘right to health’ is increasingly seen as essential to achieving healthy and equitable 
societies.  It has informed health policy reforms.41 It has been relied on in judicial 
orders for the restructure of domestic health systems.42  And, in a study of 73 access-
to-medicine cases from low and middle income countries, it has been shown that the 
‘right to health’, as articulated in these instruments and sometimes transposed into 
domestic constitutional law, has consistently been relied on by courts when extending 
medical services to claimants (and this ‘right to health’ has been variously linked to 
                                                 
32  We are generally trying to forge a society shaped by positive rights supported by legal 
protections and processes that are available to all, including scientists, the elderly, and others.  
However, as a result of individual and collective practices, that society remains, in many ways, 
aspirational. 
33  UN General Assembly Res. 217A (III), UN GAOR, 3d Sess., UN Doc. A/810, 1948, Article 
25. 
34  Available at http://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf. 
35  993 UNTS 3, Articles 9 and 12 and General Comment 3. 
36  660 UNTS 195. 
37  WHO.  Available at http://www.who.int/hpr/NPH/docs/declaration_almaata.pdf. 
38  WHO.  Available at http://www.who.int/healthpromotion/conferences/previous/ottawa/en/. 
39  1577 UNTS 44. 
40  WHO.  Available at 
http://www.who.int/healthpromotion/conferences/6gchp/hpr_050829_%20BCHP.pdf. 
41  Uganda Ministry of Health, Review of the HSSPII in Relation to Human Rights and Gender as 
Part of the Third-Term Review for the Health Sector, Second Draft (Kampala: Ministry of Health, 
2008). 
42  Tutela Decision, T-760/2008, 31 July 2008, Colombian Constitutional Court. 
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the right to life, to dignity, and to physical integrity).43 
Importantly, the elderly are entitled to their ‘right to health’ in an equitable and 
non-discriminatory manner.  Most international human rights instruments emphasise 
equality and stipulate that all rights are to be enjoyed equally by all groups; the 
elderly are not infrequently specifically identified through prohibitions against age 
discrimination, and this prohibition is reiterated with respect to enumerated health 
provisions.44  In Europe, this equality is established by the Revised European Social 
Charter (1996),45 by Protocol 11 (1998) of the European Convention on Human 
Rights (1950),46 and by the EU Charter of Fundamental Rights (2000),47 and both the 
UN and the WHO have condemned ‘ageism’, including ageism in healthcare 
provision.48 
In addition to equality and the equal protection of this ‘right to health’, the 
elderly have a number of other rights specifically directed at them and aimed at 
ensuring that they retain dignity and autonomy despite possible infirmity and 
cognitive diminishment.  For example, they have: 
 
• the right to special protection in old age, including that related to social 
security, food, specialised medical care, and social and vocational 
engagement;49 
 
• the right to special protection consistent with their needs;50 
 
• the right to dignity and independence;51 and 
 
• the right to expect public and private services designed to allow them to 
remain active members of society for as long as possible.52 
 
The UN has also articulated a number of principles with explicit health implications, 
including those of ‘independence’, ‘participation’, and ‘care’.53  With respect to 
medical research more specifically, the UN Human Rights Committee has declared 
that special protection and special attention is needed with respect to consent 
                                                 
43  H. Hogerzeil et al., “Is Access to Essential Medicines as Part of the Fulfilment of the Right to 
Health Enforceable Through the Courts?” (2006) 368 Lancet 305-311. 
44  See for example, Article 9 of the ICESCR (1966), which states that every person should be 
granted access to social security, and Article 3 of the European Convention on Biomedicine (1998) and 
Article 34 of the EU Charter of Fundamental Rights (2000), which emphasise the right to equitable 
access to healthcare of appropriate quality without discrimination. 
45  See Part I, Article E, available at http://conventions.coe.int/treaty/en/treaties/html/163.htm. 
46  See Article 14, available at http://www.echr.coe.int/NR/rdonlyres/D5CC24A7-DC13-4318-
B457-5C9014916D7A/0/ENG_CONV.pdf. 
47  See Article 21, available at http://www.europarl.europa.eu/charter/pdf/text_en.pdf. 
48  Note the UN International Year of Older Persons 1999, and see A. Kalache & I. Keller, “The 
WHO Perspective on Active Ageing” (1999) 6 Global Health Promo 20-23. 
49  Articles 9 and 17 of the Additional Protocol to the American Convention on Human Rights in 
the Area of Economic, Social and Cultural Rights (1989), OASTS 69, available at 
http://www.oas.org/juridico/english/treaties/a-52.html. 
50  Article 18 of the African Charter on Human and Peoples’ Rights (1981), 21 ILM 58. 
51  Article 25 of the EU Charter of Fundamental Rights (2000). 
52  Articles 12 and 23 of the Revised European Social Charter (1996). 
53  UN Principles for Older Persons, General Assembly Res. 46/91, UN GAOR, 46th Sess., 74th 
Plen. Meeting, Annex 1, UN Doc A/RES/46/91 (1991).  See also UN, “Report of the Second World 
Assembly on Ageing”, UN Doc. A/CONF.197/9, 2002. 
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procedures involving the elderly, particularly where their capacity is reduced.54 
In combination with the legal and social entitlements that Europeans generally 
enjoy (and expect),55 the effect of these rights is that the elderly have much higher 
aspirations than previous generations for reaching old age and for sustaining health in 
old age.56  In other words, the increased prospects that our rights society has 
generated has simultaneously generated greater demands; people do not just want 
longer life, they want an increased number of healthy life years.57  They want capacity 
and productivity.  They want ‘quality of life’ in their old age.  In the absence of robust 
health (entailing independence and productivity), they want their extended life to 
nonetheless be a life of dignity and respect.58  They want a ‘life worth living’, even if 
it is not the life they previously had, or had envisioned for themselves.  As a result of 
these wants, which are not limited to existing seniors but are also held by the 
‘anticipatory elderly’, people are demanding, and will continue to demand, more of 
their declining years, and so they are demanding, and will continue to demand, more 
of the health system and associated health research and its resultant new technologies 
and practices,59 and they are often pursuing these demands through rights claims. 
Of course, the reality is that many of the above-noted rights are ‘progressive’ 
insofar as states are expected to move towards an ideal and to make (difficult) 
decisions about how and in what order to operationalise programmes aimed at 
realising them.  This operationalisation lag means that health systems will not (and 
need not) be comprehensive, or even optimal.  States are not held to standards of 
perfection, and there is no enforceable expectation that health systems will be the 
primary policy or funding priority of governments.  In real terms, this means that 
healthcare interventions will be rationed and health research will be patchy (ie: it will 
seek solutions for some conditions at the expense of others and it will not necessarily 
be funded in a strategic manner).  However, the existence of these overlapping rights 
and the welter of reiterations and efforts to embed and realise them means that we 
should (and must) take steps whenever possible to facilitate the dissemination of 
knowledge so that more patients, including elderly patients, might benefit more 
quickly from research and its uptake in health systems, particularly when those 
elderly patients have contributed to that research in a direct way.  Even if existing 
individual elders do not materially benefit from that research, data-sharing will allow 
us (as a research community) to better and more quickly realise the ‘right to health’ 
for all.60 
                                                 
54  UN Human Rights Committee, General Comment 7: Torture or Cruel, Inhuman or Degrading 
Treatment or Punishment, UN Doc HRI/GEN/1/Rev. 1 (1994). 
55  Including strong mobility rights, increasing levels of education, widely available information 
about technological capabilities and geographic inequalities, and rising desires for varied, self-
actualising leisure opportunities. 
56  E. Rynning, “The Ageing Populations of Europe: Implications for Health Systems and 
Patients’ Rights” (2008) 15 Euro J Health Law 297-306. 
57  We recognise that desires, even those indirectly fuelled by rights, do not automatically entitle, 
much less grant, individuals the right to have those desires satisfied, but, we contend, a welfare-based 
rights society would and should endeavour, as far as possible, to deliver on the desires that our rights 
instruments feed. 
58  With respect to long life, some argue that there is no evidence that humans have reached the 
limit of life expectancy: J. Oeppen & J. Vaupel, “Demography: Broken Limits to Life Expectancy” 
(2002) 296 Science 1029-1031. 
59  For evidence of the hope being placed in new technologies, see European Commission, 
Together for Health: A Strategic Approach for the EU 2008-2013 (Luxembourg: EU Publications 
Office, 2007). 
60  Increased sharing of research and health data is also important for measuring how countries 
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In short, the elderly are important rights-holders; they are not only holders of 
the usual and universally shared rights, but also holders of rights specifically designed 
for them as vulnerable individuals.  In other words, while the elderly are a large and 
growing collection of people, they are a vulnerable group (akin to a minority) whose 
voice needs to be heard and taken into account (ie: their desires need to be realised 
through both politics and the law).61  And their desires include increased activity and 
actualisation in their late-life years.  If health-related rights and elder rights are to be 
realised, better use must be made of research funding and outputs.  This supports the 
contention that increased and improved data-sharing is important. 
 
Argument 2: Aging Populations Place Greater Demands on Healthcare Systems 
 
The second age-based argument shifts from the elderly as rights-holders to the elderly 
as change-prompters and (recidivist) users of healthcare systems.  It goes as follows: 
The inexorable growth of the elderly demographic is putting ever-increasing pressures 
on healthcare systems.  To avoid system-collapse, we must design greater efficiencies 
in health research and the translation of new knowledge into practices and products 
useful to healthcare systems.  One way of doing so is to increase data-sharing. 
Most developed countries, including European countries, are in a period of 
critical demographic shift.  From a beginning-of-life perspective, countries where 
women have been mainstreamed into the paid workforce and have therefore 
postponed childbearing have experienced dropping birth rates.  In Europe, women 
give birth to approximately 1.52 children; less than is needed to maintain the 
population in the absence of inclusive immigration policies.62  The result of this is that 
populations are expected to decrease from now to 2050 and beyond.63  In parallel with 
this beginning-of-life trend, life expectancy has been rising for the last 50+ years.  
Thus, from an end-of-life perspective, death has been ‘postponed’ with the result that 
populations are aging.  The World Health Organisation (WHO) estimates that the 60+ 
age group is the fastest growing age group in the world.64  These parallel demographic 
trends are causing, and will continue to cause, profound social, political, ethical, 
economic, and legal consequences.65 
From a health and healthcare perspective, these trends (ie: declining 
population growth on the one hand, and longer life expectancy and aging populations 
on the other) will have dramatic consequences.  It is anticipated that health and social 
programmes, and healthcare systems more generally, will be seriously burdened.66  
                                                                                                                                            
are performing with respect to health; current data practices hinder investigations into whether 
adequate and appropriate health research is being conducted in conformity with international right-to-
health demands: G. Backman et al., “Health Systems and the Right to Health: An Assessment of 194 
Countries” (2008) 372 Lancet 2047-2085. 
61  A. Kalache & I. Keller, “The Greying World: A Challenge for the Twenty-First Century” 
(2000) 83 Science Progress 33-54. 
62  European Observatory on the Social Situation, Demographic Trends, Socio-Economic Impacts 
and Policy Implications in the European Union – 2007 (Luxembourg: EU Publications Office, 2008). 
63  UN, World Population Prospects: The 2010 Revision (NY: Department of Economic & Social 
Affairs, Population Division, 2011).  Although we note that the global population has just topped seven 
billion, having grown by a billion people in just 12 years. 
64  WHO, Active Aging: A Policy Framework (Geneva: WHO, 2002). 
65  J. Gruber & D. Wise, “An International Perspective on Policies for the Aging Society”, NBER 
Working paper No. 8103, 2001, available at http://www.nber.org/papers/w8103. 
66  WHO, Active Aging: A Policy Framework (Geneva: WHO, 2002), at 17.  From a programmes 
perspective, one can already find discussions about retirement ages and the management and funding of 
pension schemes into the future: see Editorial, “70 of Bust”, 9-15 April 2011, Economist, p. 13, and P. 
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For example, people are living longer, but they are not necessarily living in good 
health; they are living longer with chronic diseases and multiple health 
conditions/ailments,67 and they are thus altering disease patterns.68  They are placing 
much greater demands on healthcare systems to offer a range of effective and 
accessible cures and/or treatments for age-related conditions, including dementia and 
old-age depression.  The pressures faced by geriatric and palliative care wards (in 
particular) and their need to offer coordinated and integrated short- and long-term care 
will be enormous and unprecedented.69  Simultaneously, a shift in the ‘old-age 
dependency ratio’ is being prompted; whereas today there are some four working-age 
people for every pensioned person, this is expected to drop to two by 2050.70  In 
addition to placing increasing pressure on working-age people, this will threaten 
existing healthcare funding models, and this at a time when healthcare systems are 
already faltering and collapsing.71 
The above will place increasing pressure on medical research to deliver 
practical and cost-effective solutions for society’s growing healthcare needs.  
Concomitantly, it will increase the pressure on research funding bodies and healthcare 
systems to realise as much value-for-money as possible through that research.  
Obviously, healthcare systems are important sources and users of new life science 
knowledge and technologies,72 but while research has delivered new technologies and 
treatments to healthcare systems, these have not typically been low-cost innovations 
capable of timely delivery to large populations, including those in lower-income 
regions/jurisdictions.73  Currently, health research and technologies often make 
                                                                                                                                            
Coggan et al., “Pensions – Falling Shorts” , 9-11 April 2011, Economist, Special Report.  From a 
systemic perspective, there are concerns about how to accommodate the growing number of geriatric 
patients.  For example, the balance in the provision of elderly care/support as between home-based 
options and long-term institutional care has shifted toward the latter as higher female employment rates 
have risen and family mobility has increased.  This balance-shift, combined with growing numbers of 
elderly people will cause acute problems: C. Masseria & E. Mossialos, Research Note: How Much 
Care for Older People will be Needed? What can Policies do to Avoid or Reduce Dependency and to 
Ensure that Adequate Care will be Available? (Luxembourg: EU Publications Office, 2006).  For an 
assessment of expected care needs in the UK, see D. Wanless, Securing Good Care for Older People: 
Taking a Long-Term View (London: King’s Fund, 2006). 
67  By 2006, life expectancy in the EU-27 was 82 years for women and 75.8 years for men: 
European Commission, The Social Situation in the European Union 2009 (Luxembourg: EU 
Publications Office, 2010) at 335.  Life expectancy in several EU countries, including the UK, is now 
higher, though discrepancies exist across national borders: D. Leon, “Trends in European Life 
Expectancy: A Salutary View” (2011) Int J Epidemiology 1-7, early online, at 
http://ije.oxfordjournals.org/content/early/2011/03/16/ije.dyr061.full.pdf+html. 
68  WHO, Life in the 21st Century: A Vision for All (Geneva: WHO, 1998). 
69  WHO Europe, “Conference Document: Health Workforce Policies in the European Region”, 
Doc. EUR/RC57/9, 30 June 2007, available at 
http://www.euro.who.int/__data/assets/pdf_file/0020/74540/RC57_edoc09.pdf. 
70  European Commission, Europe’s Demographic Future: Facts and Figures on Challenges and 
Opportunities (Luxembourg: EU Publications Office, 2007). 
71  WHO, Everybody’s Business: Strengthening Health Systems to Improve Health Outcomes 
(Geneva: WHO, 2007). 
72  Healthcare systems and health research are both important sources and users of life science 
knowledge and innovative technologies: European Commission Communication, Modernising Social 
Protection for the Development  of High-Quality, Accessible and Sustainable Health Care and Long-
Term Care: Support for National Strategies Using the ‘Open Method of Coordination’, 
COM/2004/0304 Final, available at http://eur-
lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=en&type_doc=COMfina
l&an_doc=2004&nu_doc=304. 
73  Medical technologies include drugs, diagnostic tools, screening devices, and non-drug 
therapies. 
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healthcare delivery more expensive: 
 
To date, advancing technology would seem to have pushed up overall 
spending – i.e. by the introduction of new expensive pharmaceuticals 
and investments in new systems instruments – rather than saving 
money.74 
 
This is reiterated by the WHO, which reports that, rather than old age per se driving 
healthcare costs: 
 
… the major causes of escalating healthcare costs are related to … 
[i]nefficiencies in care delivery … payment systems that encourage 
long hospital stays, excessive numbers of medical interventions, and 
the inappropriate use of high cost technologies. … For example, in the 
United States and other OECD countries, new technologies were 
sometimes rapidly introduced and used where alternative and less 
expensive procedures already existed, and for which the marginal 
effectiveness was relatively low.75 
 
This trend cannot be sustained as the number of elderly climb and the number of 
financial contributors to the research undertaking and to healthcare systems decline.76  
If it does continue, it could lead to systemic collapse, but before doing so, it would 
almost certainly make (access to) healthcare highly inequitable (or rather dramatically 
more inequitable than at present). 
If governments take Humphrey’s admonition seriously – and they should – 
then they must consider how to get the most out of health research activities so that 
those activities contribute in a real and beneficial way to healthcare delivery in a 
context defined by widespread agedness.  They must ensure that new knowledge 
reaches, is tested, and is ultimately deployed by the most, and most appropriate, 
people in a timely fashion despite shrinking health system support and research 
investment.  All of this, quite clearly, points to a need to pay much greater attention to 
effective and efficient data-sharing, which invariably extracts more value from 
research data and spreads knowledge to wider and more diverse users.  Related to the 
issue of healthcare system operation in an aging context, there is also a need to more 
effectively share health records across and between systems as elder patients move 
jurisdictions to be with or closer to family. 
 
Argument 3: Elderly Research Participants Deserve Reciprocity 
 
Whereas the first argument was legal and the second systemic/policy, this third and 
last age-related argument is moral; it turns on how elderly participation in research 
                                                 
74  E. Rynning, supra, note 56, at 303.  Examples of research-driven innovations that have 
entered healthcare systems are pre-natal genetic diagnostics and improved fertility treatments, which 
are highly technical and expensive, and therefore of limited use.  It has been noted that recent health 
and medical improvements, including in life expectancy, have been enjoyed primarily by the socio-
economically advantaged, not by the disadvantaged: D. Leon, supra, note 67. 
75  WHO, Active Aging: A Policy Framework (Geneva: WHO, 2002), at 42. 
76  See V. Fuchs, “Health Care for the Elderly: How Much? Who Will Pay for It?” (1999) 18 
health Affairs 11-21, who, analysing the US context, reported that if trends to 1995 continue until 2020, 
healthcare consumption by the elderly will be some US$25,000 per person (in 1995 dollars) compared 
with $9,200 in 1995. 
 13 
squares with some of the socio-moral values felt to be critical to the life science 
undertaking and to healthcare more generally.  We argue that elder participation in 
research studies, and thereby their interaction with these values, is such that their 
contributions can, more than others’, be characterised as purely altruistic.  On the 
basis of reciprocity and solidarity, they are owed something for their socially valuable 
and personally burdensome contribution.  One option is to accelerate research outputs 
through improved data-sharing. 
We begin with a consideration of one of the foundational concepts in the 
research recruitment and donation setting: altruism.  Theories of altruism can be 
found in Chinese, Greek, and Roman philosophies, as well as in the Torah and New 
Testament.77  Without claiming the term itself (which was coined in 1851 by Auguste 
Comte), Adam Smith captured the meaning of altruism.  Emphasising the 
quantitative, he said: 
 
How selfish soever man may be supposed, there are evidently some 
principles in his nature which interest him in the fortune of others, and 
render their happiness necessary to him, though he derives nothing 
from it except the pleasure of seeing it.78 
 
Socio-biologists adopt a similarly quantitative description, defining ‘altruism’ as an 
act that benefits the actor less than the recipient.79  Economists define ‘altruistic 
behaviour’ as conduct that could have resulted in better outcomes for the actor had 
she chosen to ignore the effect of her choice on others.80  Game theorists label 
‘altruists’ as individuals who give more weight to others’ outcomes than to their own 
in deciding strategies.81 
Other definitions emphasise the qualitative; while not ignoring the cost-benefit 
balance to the actor, they focus on intentions and motivations.  Thus, they suggest that 
altruistic behaviour must:82 
 
1. benefit a third person; 
2. be performed with the intention of such benefit and no other purpose; 
3. be performed without expectation of personal reward; and 
4. be performed voluntarily and intentionally. 
 
Altruism is thus juxtaposed with egoism, the latter which is a motivational state 
characterised by a self-oriented aim to increase one’s own welfare.83 
                                                 
77  A. Midlarsky & E. Kahana, “Altruism, Well-Being and Mental Health in Late Life” in S. Post 
(ed.), Altruism and Health: Perspectives from Empirical Research (Oxford: OUP, 2007) 56-69. 
78  A. Smith, The Theory of Moral Sentiments, 6th ed. (London: A. Millar, 1790), at I.I.1. 
79  J. Piliavin & HW. Charng, “Altruism: A Review of Recent Theory and Research” (1990) 16 
Ann Rev Sociology 27-65.  Some have gone so far as to describe it as self-destructive behaviour 
performed for the benefit of others: E. Wilson, Sociobiology: The New Synthesis (Cambridge: Harvard 
U Press, 1975). 
80  H. Margolis, Selfishness, Altruism and Rationality (Cambridge: CUP, 1982). 
81  W. Liebrand, “The Ubiquity of Social Values in Social Dilemmas” in A. Wilke et al. (eds.), 
Experimental Social Dilemmas (Frankfurt: Verlag Peter Lang, 1986) 113-134. 
82  J. Macaulay & L. Berkowitz (eds.), Altruism and Helping Behavior (NY: Academic Press, 
1970), D. Bar-Tal, “Altruistic Motivation to Help: Definition, Utility and Operationalisation” (1985-86) 
13 Humboldt J Soc Relations 3-14, and D. Krebs, “The Challenge of Altruism in Biology and 
Psychology” in C. Crawford et al. (eds.), Sociobiology and Psychology (NJ: Earlbaum, 1987) 81-118. 
83  G. Lewes, Comte’s Philosophy of the Sciences (London: George Bell, 1904), and C. Batson, 
“Experimental Tests for the Existence of Altruism” in Philosophy of Science Association (ed.), PSA: 
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Regardless of the definitional emphasis adopted (quantitative or qualitative), 
theorists discern two different types of altruism: one is impulsive, spontaneous, 
reflexive, or unconscious and often directed at kin;84 the other is more conscious and 
considered and in response to perceived social needs and expectations.  This latter 
type captures the idea of ‘generalised altruism’ described by Alexander.85  While it has 
been noted that altruism need not necessarily produce ‘pro-social behaviour’, it can 
and very often does result in such behaviour.86 
Modern medical research relies on unpaid human tissue donation and the 
opening up of personal data to researchers (ie: which relies on altruistically given 
‘gifts’87), and it involves both altruism typologies being translated into pro-social 
behaviour.  Unsurprisingly (and sadly), pure altruism is a relatively rare 
phenomenon.88  However, elder participation in research – which is now pressing as 
age-related conditions become more ubiquitous and taxing upon healthcare systems – 
might be characterised as closer to pure altruism than that of any other group.  This is 
so for at least three reasons: 
 
• First, elder participants often face heavier burdens as a cost of participation. 
For example, as people become infirm, simple matters of accessing and 
enduring transportation become significant barriers, and transportation has 
been identified as a recruitment challenge.89  In addition, depending on the 
study, individuals may be asked to put at risk their already tenuous grip on 
good health.90  Another burden born most heavily by elderly participants is 
availability of, and access to, services (not just health services) to support 
them in their activities or assist them if their health is impaired by the study.91 
 
• Second, because of the length of time it takes to move new knowledge from 
‘bench to bedside’, elder participants will not likely see (nor will most expect 
to see) the ultimate fruits of their participation.  By comparison, younger 
participants, rightly or wrongly, will often expect to benefit down the road 
from the knowledge to which their participation contributes.  In short, for 
many types of research, elder participants will rarely gain any instrumental 
individual health benefit, and may in fact suffer at least minor net health 
                                                                                                                                            
Proceedings of the Biennial Meeting of the Philosophy of Science Association  (Chicago: PSA, 1992) 
69-78. 
84  Although it is often extended more broadly – to strangers – in emergency situations. 
85  R. Alexander, The Biology of Moral Systems (NY: Aldine, 1987). 
86  J. Piliavin & HW. Charng, supra, note 79, J. Piliavin et al., Emergency Intervention (NY: 
Academic Press, 1981), M. Hoffman, “Is Altruism Part of Human Nature?” (1981) 40 J Pers Soc 
Psychol 121-137, I. Vine, “Sociobiology and Social Psychology: Rivalry or Symbiosis?” (1983) 22 
British J Soc Psychol 1-11, J. Hill, “Human Altruism and Sociocultural Fitness” (1984) 7 J Soc Bio 
Struct 17-35, N. Eisenberg & P. Miller, “The Relation of Empathy to Prosocial and Related Behaviors 
(1987) 101 Psychol Bull 91-119, and C. Batson & A. Powell, “Altruism and Prosocial Behavior” in I. 
Weiner (ed.), Handbook of Psychology (UK: Wiley Online, 2003) 463-484. 
87  R. Titmuss, The Gift Relationship (London: Penguin Books, 1973). 
88  So claimed by C. Batson & A. Powell, supra, note 86. 
89  L. Lovato et al., “Recruitment for Controlled Clinical Trials: Literature Summary and 
Annotated Bibliography” (1997) 18 Controlled Clin Trials 328-357. 
90  M. Boles et al., “Primary Prevention Studies and the Healthy Elderly: Evaluating Barriers to 
Recruitment” (2000) 25 J Community Health 279-292. 
91  For access issues in the UK, see Department of Health, National Service Framework for Older 
People (London: DoH, 2001) and Department of Health, National Service Framework for Older 
People: A Report of Progress and Future Challenges (London: DoH, 2003). 
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deficits as a result of contributing. 
 
• Third, elder participants make this contribution to society despite the fact that 
they, as a group and individually, are marginalised by that society and are thus 
properly recognised as a ‘vulnerable group’.  For example, they often 
experience institutional, spatial, and cultural age segregation.92  This, 
combined with the onset of disability and the (oft-experienced) reality of 
subsisting on (low) fixed incomes,93 further marginalises them and impacts 
negatively on their happiness and social status.94  Finally, social roles, which 
serve to build and maintain connections between individuals, are frequently 
lost, thereby decreasing wellbeing, and they are not adequately compensated 
for (or replaced) by social institutions.95  On top of all this, they are often 
accused of failing to make valuable contributions to society,96 despite typically 
outperforming younger demographic groups in pro-social activities.97 
 
Despite these burdens, the elderly do participate, and they have cited a desire to 
contribute to science and improve the health of others as motivating factors.98  For 
those who believe in a moral duty to participate, the sense of fulfilment of that duty 
can be a particularly strong motivator.99  This says something about the quality of 
elder participation in research; it suggests that their participation is more virtuous than 
that of other groups because it costs them more and offers them less in material return.  
Having said this, we acknowledge that the elderly may experience some intangible 
but very real benefits from participation: empirical research has demonstrated that 
helping others promotes personal satisfaction, confidence, self-esteem, and social 
integration (ie: it improves self-perceptions about quality of life), as well as social 
(re)integration, which, in turn, contributes to emotional wellbeing.100 
                                                 
92  G. Hagestad, “Should We Be Concerned About Age Segregation?” (2006) 28 Research on 
Aging 638-653. 
93  Particularly women over 65 living alone: European Commission, The Social Situation in the 
European Union 2009 (Luxembourg: EU Publications Office, 2010), at 6. 
94  A. Walker, “The Social Creation of Poverty and Dependency in Old Age” (1980) 9 J Soc 
Policy 49-75, and A. Deaton, “Income, Aging, Health and Well-Being Around the World: Evidence 
from the Gallup World Poll” in D. Wise (ed.) Research Findings in the Economics of Aging (Chicago: 
U Chicago Press, 2010) 235-263. 
95  P. Thoits & L. Hewitt, “Volunteer Work and Well-Being” (2001) 42 J Health Soc Behaviour 
115-131. 
96  Noted by S. Giordano, “Respect for Equality and the Treatment of the Elderly: Declarations of 
Human Rights and Age-Based Rationing” (2005) 14 Cambridge Q Healthcare Ethics 83-92. 
97  A. Midlarsky & E. Kahana, “Altruism, Well-Being and Mental Health in Late Life” in S. Post 
(ed.), Altruism and Health: Perspectives from Empirical Research (Oxford: OUP, 2007) 56-69. 
98  E. Schron et al., “Clinical Trial Participant Satisfaction: Survey of SHEP Enrollees” (1997) 45 
J Am Geriatric Soc 934-938. 
99  See E. Kahana et al., “Beyond Dependency, Autonomy and Exchange: Pro-social Behaviour in 
Late Life Adaptation” (1987) 1 Soc Justice Res 439-459,and E. Midlarsky & E. Kahana, Altruism in 
Later Life (California: Sage Publications, 1994), who report that a sense of duty often motivates older 
adults, who are, in fact, more probable to have altruistic motivations than other groups. 
100  See D. LeBlanc, “Case Studying the Philosophy, Integrity and Emotional Health of the 
Elderly” (1987) 13 Edu Gerontology 387-402, R. Cialdini & J. Fultz, “Interpreting the Negative Mood 
– Helping Literature via ‘Mega’-Analysis: A Contrary View” (1990) 107 Psychological Bull 210-214, 
J. Piliavin & P. Callero, Giving Blood (Baltimore: Johns Hopkins U Press, 1991), E. Midlarsky, 
“Helping as Coping” in M. Clark (ed.), Review of Personality and Social Psychology (Cal: Sage, 1991) 
238-264, K. Pillemer et al. (eds.), Social Integration in the Second Half of Life (Baltimore: Johns 
Hopkins U Press, 2000), M. Snyder et al., “The Functional Approach to Volunteerism” in R. Maio & J. 
Olson (eds.), Why We Evaluate: Functions of Attitudes (NJ: Erlbaum, 2000) 365-393, and P. Sorokin, 
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In any event, perhaps in recognition of the fact that pure altruism is so rare, 
but with a view to maintaining social relationships, some argue that gifts should be 
met with some reciprocation which both encourages further acts of giving and 
embodies the spirit of mutual support (solidarity) within a community.101  So while 
one can accept, reject, or ignore a gift, once accepted, the recipient, who has 
presumably benefited from the gift, must offer something in return.102  Importantly, 
that reciprocation need not go to the original giver.  The concept of ‘third-party 
altruism’ is that the giver does not expect something for themselves, but rather 
something for a third party; the receiver should reciprocate the gift by conferring 
rewards on others.103  This transforms the gift relationship into a multi-person 
relationship grounded on social cooperation (solidarity again). 
As suggested, this reciprocation implicates and is grounded on the solidarity 
value.  The EU Ministers of Health have identified solidarity as a core value 
fundamental to health systems, which themselves are integral to Europe’s social 
infrastructure.104  They have defined solidarity as being closely linked to the financial 
and access arrangements relating to national health systems.105  While they rightly 
acknowledge the proximity of solidarity to universal access and equality, their 
definition is overly narrow and wrongly collapses solidarity into financial conditions 
and other separately articulated values.  Though solidarity has many roots and 
conceptions, the following propositions better capture its socio-moral content: 106 
 
• Solidarity recognises that individuals are naturally and irrevocably embedded 
in social contexts; they are in a state of interrelationship or interconnectedness 
with individuals, groups and society.  It therefore emphasises community. 
 
• Solidarity is grounded in compassion, fraternity and a genuine interest in the 
well-being of others, the ultimate goal being to construct, through personal 
and collective actions, a just/decent and fair society.  It therefore emphasises 
equality and the active promotion of welfare. 
 
• Solidarity demands common action to uphold the complex of social 
relationships and values that is needed to realise useful standards of decency 
and justice.  It therefore emphasises the role of duties flowing from and toward 
individuals and communities, and may require collective interests to take 
priority over the interest of individuals or sub-collectives. 
 
While altruism may move the elderly to act, solidarity demands that we, as a research 
community and a society, appropriately reciprocate the contributions made by elderly 
participants.  This reciprocation has the effect of completing the act of solidarity 
begun by the elder participant.  It is incumbent on researchers to take the lead in 
closing this circle.  If researchers fail to do so appropriately (or meaningfully), they 
                                                                                                                                            
The Ways and Power of Love (Penn: J Templeton Foundation Press, 2002). 
101  M. Mauss, The Gift (Oxford: Routledge, 1990), at 50-54. 
102  A. Komter, Social Solidarity and the Gift (Cambridge: CUP, 2005), at 116-117. 
103  R. Trivers, “The Evolution of Reciprocal Altruism” (1971) 46 Quart Rev Biology 35. 
104  Council of the European Union, “Council Conclusions on Common Values and Principles in 
European Union Health Systems” (2006) Official J EU C146/1-3. 
105  Ibid, Annex. 
106  See the discussion in S. Harmon, “Solidarity: A (New) Ethic for Global Health Policy” (2006) 
14 Health Care Analysis 215-236. 
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abuse the elder participants’ (often costly) altruistic choice by undermining the basis 
(or one of the bases) upon which the choice was made, which, as noted, is to benefit 
society through research that will improve the health of others. 
How can this circle be closed? 
The most obvious and effective way, and the most appreciated by elder 
participants, who have a unique relationship with the research undertaking, is to 
generate new knowledge and share it with humanity and with other specialists who 
can put it to work.  Improved data-sharing – data-sharing that is more widely 
practiced, more efficiently realised, and performed earlier in the research process – is 
the most valuable and traceable means of meeting our reciprocation responsibilities to 
elderly participants.  Data-sharing is a useful but necessary ‘in-pipeline’ response 
because, as noted, elderly participants will not likely see the end product.  Their 
‘higher’ or ‘purer’ altruism, which is becoming more important as work on age-
related conditions becomes more pressing, necessitates reciprocating actions (actions 
which additionally serve to help operationalise their rights as outlined above), and 
improved data-sharing is an appropriate vehicle for doing so. 
 
CONCLUSIONS 
 
Knowledge is a socio-moral or human value, and therefore the generation of 
knowledge is a valuable pursuit.  If the biosciences are to fulfil their promise of both 
generating knowledge and translating that knowledge into socially beneficial products 
and practices, then research data and subsequent findings must be shared widely and 
rapidly.  If support for this practice beyond the scientific were needed, the vulnerable, 
with the elderly as an example thereof, surely provide that support.  As demonstrated 
above, they do so in three important ways: 
 
1. Argument 1: As rights holders who have (presumably) contributed to society 
for a longer period than any other group, they are entitled to expect maximum 
value from research which interacts with and facilitates their health, equality, 
and elder rights in a variety of ways. 
 
2. Argument 2: As a growing demographic which will inevitably become more 
demanding of healthcare (thus exerting increased stress on already precarious 
healthcare systems), they serve as a reason to rethink how those healthcare 
systems and their feeder research systems work.  Their growing prominence as 
a social group forces us to think more carefully about how we make the 
transition from bench-to-bedside more efficient. 
 
3. Argument 3: As altruists of a higher order who are additionally more pro-
social than other groups, they are owed some real and measurable return on 
their contributions, particularly in light of their fleeting expectations of 
actually enjoying new treatments to which they might have contributed. 
 
Again, while all of these propositions/arguments are coloured by morality, they are 
quite different arguments; one is based in law and legal instruments, one in health 
systems and how they respond in practice to new pressures, and one in 
medical/research ethics.  Additionally, we do not necessarily see one argument as 
being more convincing or more weighty than the others; they are equally important 
and potentially equally compelling.  But to help us realise the ideal situation, all three 
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must feed into the consideration. 
But how do we realise the improved data-sharing that the elderly are due?  
This is a technical question which researchers, research funders, and research 
policymakers need to address in a holistic way, and in short order.107  The already 
existing variety of policies and instruments which aim to entrench core data-sharing 
practices have not succeeded. 
What can be done? 
As a start, we might consolidate and rationalise the many (non-binding) 
statements that exist, taking full stock of where different biomedical research fields 
are with respect to data-sharing.  Funders should adopt and enforce harmonised 
practices (and standardised practices where appropriate).  Ultimately, however, and 
because a lot of this research is publicly funded (or alternatively relies in no small part 
on publicly funded research), the law has a valid and important role to play; it should 
be deployed to facilitate and enforce increased data-sharing in biomedical research.  A 
normative (legal) approach is preferred because it can advance autonomy, encourage 
solidarity, and reward altruism all at the same time.  In doing so, the law can 
enumerate and enforce best practices for a range of settings (eg: publicly funded 
research should meet stronger minimum levels of data-sharing; private research 
should have a legal responsibility to negotiate with participants data-sharing levels 
above and beyond that, or, if lower, should clearly defend this lower level to 
participants and Research Ethics Committees).108  Of course, we must reiterate that 
our intention is to make the argument for greater and/or improved data-sharing, not to 
offer a bespoke legal regime for doing so.  As should be clear from the above, we see 
that as a collaborative and international undertaking (but one which would result in a 
necessarily international legal instrument). 
While the metaphors of velocity (ie: inertia, acceleration, speed, races) that are 
often associated with biomedical research are usually hyperbolic, misplaced, and 
largely counter-productive,109 the proper valuing of the elderly (as contributors to 
society and research to whom respect and duties are owed) demands that we 
reconsider these metaphors; they do take on a new seriousness.  While pace can never 
be a core objective of good science, the idea of doing science well (ie: doing it 
effectively and efficiently so that outputs are correct, socially useful, and, importantly, 
timely) is profoundly appropriate and very much here implicated.  We conclude that 
increased and more effective data-sharing is most appropriate from the perspective of 
the elderly insofar as it will promote the rapid advancement of knowledge and better 
distribution of scientific knowledge and benefits, all of which is particularly important 
to aging populations. 
                                                 
107  By ‘holistic’ we mean that stakeholders must take a broad and encompassing or inclusive view 
of the field and its relevant regulatory components and make changes in a joined-up way, so that 
alterations at one point are appropriately recognised or carried through at other points. 
108  It is appropriate to separate the two regimes because governments have a duty to promote and 
realise health under international law, which duty is not imposed on individuals in the same way. 
109  See B. Nerlich et al. (eds.), Communicating Biological Sciences (Surrey: Ashgate, 2009). 
